Specialized in liquid pharmaceuticals: Blow-Fill-Seal (BFS) technology and Nasal Spray.

Read More


Your partner in bringing medical innovation to the market.

Read More

About Curida

Highly skilled Development and Manufacturing Organization with ambitions.

Read More

Contact Curida

Pharmaceutical Development or Manufacturing needs?

Contact Us

Operational Excellence in Pharmaceuticals since 1974

Curida is a Contract Development and Manufacturing Organization (CDMO) within the Pharmaceutical industry, based in Norway.

Curida has core competency in state-of-the-art manufacturing of Liquid Pharmaceuticals based on sterile unit-dose Blow-Fill-Seal (BFS) technology and Nasal Spray. The development expertise covers the full service for the development of nasal drug products, and experience on operational excellence is spanning more than 40 years. Curida has produced BFS products since 1989 and offers over three decades of know-how in this technology. Customers range from small start-ups and early stage Biotech companies to Big Pharma.

Curida is a part of an exciting and growing life science sector in Norway, and our vision is to be the National Centre for Industrialization of Medical Innovation. Curida is an active partner and member of Oslo Cancer Cluster.

Latest News

Governmental fund Investinor invests in Curida

Published: 23 Jan 2018

(Elverum, January 19th, 2018) Investinor, funded by the Norwegian government, invests 25 MNOK in the pharmaceutical development and manufacturing company Curida. The company has raised in total 75 MNOK. Canica and Klaveness Marine invested 25 MNOK each in December 2017. […]

Read More

Curida acquires Norwegian pharmaceutical manufacturer

Published: 05 Jan 2018

(Elverum, 3 January 2018) Curida has completed the acquisition of the Norwegian pharmaceutical manufacturer Ås produksjonslab. Ås produksjonslab has a long history in manufacturing a range of liquid products for Norwegian pharmacies. The company can also do contract manufacturing for […]

Read More